Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains.
Adaptive immunity
Immunology
Molecular genetics
Monogenic diseases
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
medline:
28
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
aheadofprint
Résumé
AIOLOS, also known as IKZF3, is a transcription factor highly expressed in the lymphoid lineage and critical for lymphocyte differentiation and development. Here we report nine individuals from three unrelated families carrying AIOLOS variants Q402* or E82K leading to AIOLOS haploinsufficiency through different mechanisms of action. Nonsense mutant Q402* displayed abnormal DNA binding, pericentromeric targeting, post-transcriptional modification, and transcriptome regulation. Structurally, the mutant lacks the AIOLOS zinc finger (ZF) 5-6 dimerization domain, but is still able to homodimerize with WT AIOLOS and negatively regulate DNA binding through ZF1, a previously unrecognized function for this domain. Missense mutant E82K showed overall normal AIOLOS functions; however, by affecting a redefined AIOLOS protein stability domain, it also led to haploinsufficiency. AIOLOS haploinsufficiency patients showed hypogammaglobulinemia, recurrent infections, autoimmunity and allergy, but with incomplete clinical penetrance. Altogether, these data redefine AIOLOS structure-function relationship and expand the spectrum of AIOLOS-associated diseases.
Identifiants
pubmed: 38015619
pii: 172573
doi: 10.1172/JCI172573
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM